MTOR and hepatocellular carcinoma: Moreover, RPS6K, which phosphorylates RPS6, is up-regulated in HCC patients when compared with normal ones, and this up-regulation is linked to the activation of Akt-mTOR-p70S6K signaling pathway that promotes neoangiogenesis in HCC [80,81].